Any factors or molecules, which could stabilize KLF2 protein level, would be promising for treatment of inflammatory diseases (such as RA, atherosclerosis, sepsis, etc.)and also in the expansion of T-reg populations (for treatment of autoimmune diseases). The gene discussed is KLF2; the disease is atherosclerosis.